Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tuma

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|December 27, 2007
Reactive oxygen species may have antitumor activity in metastatic melanomaRabiya S Tuma
Journal of the National Cancer Institute|June 12, 2008
Better prioritization may speed approval of adjuvant therapies in breast cancerRabiya S Tuma
Journal of the National Cancer Institute|June 23, 2011
Strides in melanoma announced: maximizing value comes nextRabiya S Tuma
Journal of the National Cancer Institute|November 22, 2011
Large-scale genome projects enter the clinic on both sides of the AtlanticRabiya S Tuma
Journal of the National Cancer Institute|September 17, 2009
Epigenetic therapies move into new territory, but how exactly do they work?Rabiya S Tuma
Journal of the National Cancer Institute|January 19, 2011
Getting around PLX4032: studies turn up unusual mechanisms of resistance to melanoma drugRabiya S Tuma
Journal of the National Cancer Institute|August 10, 2010
Large trials, small gains: is change on the way?Rabiya S Tuma
Journal of the National Cancer Institute|July 10, 2010
Thirdhand smoke: studies multiply, catchy name raises awarenessRabiya S Tuma
Journal of the National Cancer Institute|May 26, 2010
New tests for prostate cancer may be nearing the clinicRabiya S Tuma
Journal of the National Cancer Institute|July 30, 2009
Genome-wide association studies provoke debate and a new look at strategyRabiya S Tuma
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|December 27, 2007
Reactive oxygen species may have antitumor activity in metastatic melanomaRabiya S Tuma
Journal of the National Cancer Institute|June 12, 2008
Better prioritization may speed approval of adjuvant therapies in breast cancerRabiya S Tuma
Journal of the National Cancer Institute|June 23, 2011
Strides in melanoma announced: maximizing value comes nextRabiya S Tuma
Journal of the National Cancer Institute|November 22, 2011
Large-scale genome projects enter the clinic on both sides of the AtlanticRabiya S Tuma
Journal of the National Cancer Institute|September 17, 2009
Epigenetic therapies move into new territory, but how exactly do they work?Rabiya S Tuma
Journal of the National Cancer Institute|January 19, 2011
Getting around PLX4032: studies turn up unusual mechanisms of resistance to melanoma drugRabiya S Tuma
Journal of the National Cancer Institute|August 10, 2010
Large trials, small gains: is change on the way?Rabiya S Tuma
Journal of the National Cancer Institute|July 10, 2010
Thirdhand smoke: studies multiply, catchy name raises awarenessRabiya S Tuma
Journal of the National Cancer Institute|May 26, 2010
New tests for prostate cancer may be nearing the clinicRabiya S Tuma
Journal of the National Cancer Institute|July 30, 2009
Genome-wide association studies provoke debate and a new look at strategyRabiya S Tuma
Pageof 11